Escin, a natural mixture of triterpene saponins, exhibits antitumor activity against hepatocellular carcinoma

Planta Med. 2009 Dec;75(15):1580-5. doi: 10.1055/s-0029-1185838.

Abstract

Escin, a mixture of triterpene saponins extracted from Aesculus wilsonii Rehd., was used to analyze the antitumor effect in hepatocellular carcinoma in vivo and in vitro. At a dose of 2.8 mg/kg, escin had a rather high inhibition ratio (43.5 %) on mice H22 tumor growth in vivo. The results of the SRB cell viability assay showed that escin could induce significant concentration- and time-dependent inhibition of HepG (2) cell viability. Disruption of the G (1)/S phase of cell cycle progression accompanied by the induction of apoptosis were also observed in HepG (2) cells following escin treatment. The results of pulse-field gel electrophoresis and Western blot analysis show the induction of caspase-independent apoptosis by escin. This study provides evidence that escin induces cell cycle checkpoint arrest and caspase-independent cell death in HepG (2) cells, in support of its efficacious potential as a chemopreventive agent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aesculus / chemistry*
  • Animals
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Apoptosis / drug effects
  • Carcinoma, Hepatocellular / drug therapy*
  • Cell Cycle / drug effects
  • Cell Line, Tumor
  • Cell Survival / drug effects*
  • Dose-Response Relationship, Drug
  • Escin / pharmacology
  • Escin / therapeutic use*
  • Female
  • Hep G2 Cells
  • Humans
  • Liver Neoplasms / drug therapy*
  • Mice
  • Mice, Inbred Strains
  • Phytotherapy
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents, Phytogenic
  • Plant Extracts
  • Escin